Jonathan Angel profile picture

Contact Information

Jonathan Angel, MD, FRCPC
(613) 737-8442
jangel@ohri.ca

ORCID logo https://orcid.org/0000-0003-3102-4462

News

Ottawa-area residents invited to participate in multivalent COVID-19 vaccine trial
October 5, 2022 - Healthy adults are invited to participate in a clinical trial at The Ottawa Hospital to test a multivalent coronavirus vaccine candidate developed by VBI Vaccines Inc., a biotechnology company with Ottawa-based research and development facilities.
Virus versus virus: novel approach shows promise against HIV in lab study
July 12, 2021 - Thanks to the development of effective drugs, HIV has become a chronic, treatable condition for most people. But it still isn’t curable, and that isn’t good enough for Dr. Jonathan Angel and his colleagues.
The Ottawa Hospital contributes to ‘a beautiful evolution’ in HIV research and care
December 4, 2020 - In honour of World AIDS day, we take a look back at how The Ottawa Hospital played a major role in caring for patients with HIV, how it continues to lead life-saving research, and how it is transforming how HIV is managed today.
The Ottawa Hospital awarded six CIHR grants worth $2.6 million
September 7, 2020 - Could a common diabetes drug help prevent ovarian cancer? Can a tailored screening program help prevent eye disease in immigrants? Is sepsis different in females versus males, and if so, can this help us develop better treatments? These are just ...
The next frontier in HIV research: Ottawa scientists to play key role in new $17M prevention and cure studies
August 14, 2019 - Despite great strides in HIV research, over 75,000 Canadians are living with HIV and approximately seven more contract it every day. And this incurable virus continues to take a huge toll around the world. The Government of Canada recently ...
Using viruses to fight viruses: new approach eliminates “dormant” HIV-infected cells
December 18, 2017 - While Ottawa researchers are known for their work on cancer-fighting viruses, one team is applying these viruses to a new target: HIV. Researchers at The Ottawa Hospital and the University of Ottawa have discovered that the Maraba virus, or MG1, c
HIV kept at bay with single injection every 8 weeks
August 17, 2017 - Over the last two decades, HIV has been transformed from a death sentence into a chronic, treatable disease, requiring just a single pill a day to keep the virus at bay for most people. A study co-authored by Dr. Jonathan Angel has now paved the wa
Ottawa researchers to play major role in $8.7M research project aimed at curing HIV
November 28, 2013 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa (uOttawa) will play a major role in a new research project that aims to find a cure for HIV and contribute to the global effort to put an end to AIDS. The project was awarded $8.
Ottawa research could reduce use of unnecessary medications in people with HIV
December 16, 2011 - New research led by Dr. Jonathan Angel could spare many people with HIV from having to take unnecessary antibiotics associated with major side effects. A systematic review by Dr. Angel and his colleagues showed that when viral levels are suppressed,